EUVIMEDEUVIMED entdecken
Crossref

Discovery and Validation of a New Biomarker Integrating Ferroptosis and Glycolysis‐Related Genes in Bladder Cancer

Chenyang Wang, Yuncong Shu, Jiaqi Shan, Kunpeng Li, Shun Wan, Siyu Chen, Xiaoran Li, Jiping Niu, Li Yang iD

IUBMB Life · 2025

DOI: 10.1002/iub.70028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, 2025. Verfasst von Chenyang Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Lanzhou University Second Hospital, Lanzhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Glycolysis, Urinary Bladder Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Special Fund Project for Central Guiding Local Science and Technology Development, Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital, Investigation of the Effects and Mechanisms of HTRA1 on Bladder Tumors Through Combined Non-invasive Urinary Metabolomics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer (BCa) is a highly invasive tumor with few successful therapies, and its unfavorable prognosis mainly stems from late diagnosis and resistance to treatment. Ferroptosis is a type of non‐apoptotic cell death characterized by iron‐dependent regulated necrosis due to extensive lipid peroxidation. Glycolysis is fundamental to cancer cell metabolism, with cancer cells developing various strategies to enhance this process. In this study, we combined ferroptosis and glycolysis gene sets, two biological processes closely related to tumorigenesis and development, and obtained ferroptosis and glycolysis‐related gene sets (FGRGs). By leveraging both single‐cell and bulk transcriptome data from BCa, we have investigated the presence and role of FGRGs in the onset and progression of BCa through various approaches. Using machine learning algorithms, we identified a feature gene set consisting of 13 genes in the TCGA data set to predict the prognosis of BCa and verified it in the GEO data set. After that, we explored FGRGs in depth using a variety of bioinformatics analyses, such as mutational landscape analysis, functional enrichment analysis, immune infiltration analysis, FGRGs‐associated risk and clinical characterization, and drug susceptibility analysis. Finally, we validated the function of the core gene chondroitin polymerizing factor 2 (CHPF2) using CCK‐8, clone formation, transwell, and wound healing assays. Our research innovatively combines ferroptosis with glycolytic genes and applies it as an independent prognostic factor in the study of BCa. It reveals new characteristic genes and therapeutic targets that can predict the prognosis of BCa patients and lays a foundation for the study of the occurrence and development mechanism of BCa and targeted data strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisGlycolysisUrinary Bladder NeoplasmsBiomarkers, TumorHumansGene Expression Regulation, NeoplasticPrognosisCell Line, TumorComputational BiologyTranscriptomeMachine Learning

Stichwörter der Autor:innen

biomarkerbladder cancerferroptosisglycolysisprognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Lanzhou University Second Hospital, Lanzhou, China.
  • Gansu Province Clinical Research Center for Urology, Lanzhou University Second Hospital, Lanzhou, China.
  • School of Life Science, Lanzhou University, Lanzhou, China.
  • School of Medicine, Hubei Minzu University, Enshi, China.

ORCID-Profile: Li Yang

Förderung

  • Special Fund Project for Central Guiding Local Science and Technology Development
  • Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital
  • Investigation of the Effects and Mechanisms of HTRA1 on Bladder Tumors Through Combined Non-invasive Urinary Metabolomics
  • Key R&D Program of Gansu Provincial Department of Science and Technology

Zitieren

APA

Wang, C., Shu, Y., Shan, J., Li, K., Wan, S., Chen, S., Li, X., Niu, J., & Yang, L. (2025). Discovery and Validation of a New Biomarker Integrating Ferroptosis and Glycolysis‐Related Genes in Bladder Cancer. IUBMB Life. https://doi.org/10.1002/iub.70028

Vancouver

Wang C, Shu Y, Shan J, Li K, Wan S, Chen S, et al. Discovery and Validation of a New Biomarker Integrating Ferroptosis and Glycolysis‐Related Genes in Bladder Cancer. IUBMB Life. 2025. doi:10.1002/iub.70028

BibTeX
@article{Wang2025,
  author = {Wang, Chenyang and Shu, Yuncong and Shan, Jiaqi and Li, Kunpeng and Wan, Shun and Chen, Siyu and Li, Xiaoran and Niu, Jiping and Yang, Li},
  title = {Discovery and Validation of a New Biomarker Integrating Ferroptosis and Glycolysis‐Related Genes in Bladder Cancer},
  journal = {IUBMB Life},
  year = {2025},
  doi = {10.1002/iub.70028}
}
Kostenlos starten →